Search research articles
Contact Us
Filters
Showing results (331-340 of 490) with videos related to
Page
of 49
Sort By:
Orphanet Journal of Rare Diseases
|
March 7, 2026
Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients
Anteneh Amsalu, Hanif Haidari, Bianca Mirco, et al.
Orphanet Journal of Rare Diseases
|
August 13, 2022
A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa
Amy S Paller, Elena Pope, Dan Rudin, et al.
The Australasian Journal of Dermatology
|
August 26, 2025
Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation
R Cascio Ingurgio, A Alfano, E Matteodo, et al.
Pediatric Dermatology
|
September 8, 2020
Financial burden of epidermolysis bullosa on patients in the United States
Emily S Gorell, Paige W Wolstencroft, Mark P de Souza, et al.
JAAD International
|
August 5, 2024
Dermatology Journal Advisory Boards and editorial independence
Heidi Bai, Gloria Lin, Jonathan Kantor, et al.
The Cochrane Database of Systematic Reviews
|
August 12, 2023
Interventions for bullous pemphigoid
Sanjay Singh, Gudula Kirtschig, Vinayak N Anchan, et al.
Journal of the American Academy of Dermatology
|
August 25, 2009
A ski and adventure camp for young patients with severe forms of epidermolysis bullosa
Mary Alice Nading, Julien J Lahmar, John W Frew, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 1, 2016
The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa
S V Jain, A G Harris, J C Su, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 25, 2023
Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE)
Jonathan I Silverberg, Robert Bissonnette, Leon Kircik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 22, 2008
Naevus of Ota presenting in two generations: a mother and daughter
A L C Agero, J J Lahmar, R M Holzborn, et al.
Page
of 49
Search research articles
Search
Showing results (331-340 of 490) with videos related to
Sort By:
Page
of 49
Orphanet Journal of Rare Diseases
|
March 7, 2026
Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients
Anteneh Amsalu, Hanif Haidari, Bianca Mirco, et al.
Orphanet Journal of Rare Diseases
|
August 13, 2022
A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa
Amy S Paller, Elena Pope, Dan Rudin, et al.
The Australasian Journal of Dermatology
|
August 26, 2025
Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation
R Cascio Ingurgio, A Alfano, E Matteodo, et al.
Pediatric Dermatology
|
September 8, 2020
Financial burden of epidermolysis bullosa on patients in the United States
Emily S Gorell, Paige W Wolstencroft, Mark P de Souza, et al.
JAAD International
|
August 5, 2024
Dermatology Journal Advisory Boards and editorial independence
Heidi Bai, Gloria Lin, Jonathan Kantor, et al.
The Cochrane Database of Systematic Reviews
|
August 12, 2023
Interventions for bullous pemphigoid
Sanjay Singh, Gudula Kirtschig, Vinayak N Anchan, et al.
Journal of the American Academy of Dermatology
|
August 25, 2009
A ski and adventure camp for young patients with severe forms of epidermolysis bullosa
Mary Alice Nading, Julien J Lahmar, John W Frew, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 1, 2016
The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa
S V Jain, A G Harris, J C Su, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 25, 2023
Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE)
Jonathan I Silverberg, Robert Bissonnette, Leon Kircik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 22, 2008
Naevus of Ota presenting in two generations: a mother and daughter
A L C Agero, J J Lahmar, R M Holzborn, et al.
Page
of 49